Tag:
Cellzome
Latest Headlines
Latest Headlines
GSK snags proteomics platform tech in $98M Cellzome buyout
GSK has opted to buy out the company for $98 million, snagging full rights to a pair of early-stage inflammation programs and a proteomics technology.
GSK's epigenetics team tests promising leukemia drug in mice
One of the chief culprits behind infant leukemia, and a significant number of adult cases, is a fusion protein involving MLL which triggers genes that drive the development of cancer. Proteins from
Cellzome partners with GSK on inflammatory diseases
Germany's Cellzome has inked a second drug discovery pact with GlaxoSmithKline in the field of inflammatory disease. Under the terms of the agreement, Cellzome will receive about $44.79 million in
GSK signs $1.5 drug dev deal with Cellzome
GlaxoSmithKline is teaming up with Cellzome, which is developing kinase-targeted drugs, in a deal that could be worth up to $1.5 billion. The pact will target inflammatory diseases such as rheumatoid
